Toxicity and management in CAR T-cell therapy

T cells can be genetically modified to target tumors through the expression of a chimeric antigen receptor (CAR). Most notably, CAR T cells have demonstrated clinical efficacy in hematologic malignancies with more modest responses when targeting solid tumors. However, CAR T cells also have the capac...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonifant, Challice L, Jackson, Hollie J, Brentjens, Renier J, Curran, Kevin J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008265/
https://www.ncbi.nlm.nih.gov/pubmed/27626062
http://dx.doi.org/10.1038/mto.2016.11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008265/
https://www.ncbi.nlm.nih.gov/pubmed/27626062
http://dx.doi.org/10.1038/mto.2016.11

Ejemplares similares